Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials

In this analysis of the ASTRAL trials (non-opioid substitution therapy [OST], n = 984; OST, n = 51) evaluating the once-daily, pan-genotypic regimen of sofosbuvir/velpatasvir for hepatitis C virus infection, OST did not impact completion, adherence, sustained virologic response (SVR12), or safety. S...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Infect Dis
Päätekijät: Grebely, Jason, Dore, Gregory J., Zeuzem, Stefan, Aspinall, Richard J., Fox, Raymond, Han, Lingling, McNally, John, Osinusi, Anu, Brainard, Diana M., Subramanian, G. Mani, Natha, Macky, Foster, Graham R., Mangia, Alessandra, Sulkowski, Mark, Feld, Jordan J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2016
Aiheet:
Brief Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5106608/
https://ncbi.nlm.nih.gov/pubmed/27553377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw579
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia